推荐应用
Human Dendritic Cell-specific ICAM-3 Grabbing Non-integrin (DC-SIGN)/CD209 is a member of the C-type lectin family. The canonical DC-SIGN/CD209 isoform is a 46 kDa, 404 amino acid (aa) type II transmembrane protein. The extracellular region contains a Ca2+-dependent carbohydrate-binding lectin domain. Multiple human DC-SIGN/CD209 splice forms exist, generating both membrane-bound and soluble forms. DC-SIGN/CD209 is not well conserved between mouse and human, with the extracellular domain sharing only 63% aa identity. The DC-SIGN/CD209 lectin domain binds mannose oligosaccharides on pathogens including HIV as well as self glycoproteins including ICAMs. DC-SIGN/CD209 binds to butyrophilin 2A1 and this interaction can be blocked by HIV pp120. DC-SIGN/CD209 is expressed on dendritic cells (DC) and inflammatory macrophages and contributes to antigen presentation.
高纯度、高活性、低内毒素、高批间一致性
产品数据

-25 ~ -15℃保存,收到货之后有效期1年。 复溶后, 无菌条件下,-85 ~ -65℃保存,3个月有效期。
【应用方向】HER2与HER3:ErbB受体家族协同靶向治疗的核心工具蛋白
88
2026-08-31
【应用方向】HER2:抗体药物研发的核心工具蛋白
78
2026-08-31
【应用方向】抗体药研发中常见靶点蛋白及其应用
105
2026-08-31
【应用方向】靶点蛋白在抗体药研发中的应用
86
2026-08-31
【应用方向】GPC3:HCC靶向治疗的核心靶点与药物研发探索
1810
2026-04-24
【应用方向】TROP2:从分子机制到实体瘤靶向治疗的研究进展
1796
2026-04-24
【应用方向】4-1BB-4-1BBL共刺激轴的T细胞活化机制
1086
2026-04-22
【应用方向】TNFR蛋白家族概述
1028
2026-04-21
【应用方向】Klotho蛋白:编织生命之线的抗衰老分子
1176
2026-04-20
【应用方向】药靶明星 | FGFRs家族蛋白解析
888
2026-04-20
【应用方向】解析Fc受体:抗体药物研发的核心靶点与评价基石
907
2026-04-20
【应用方向】FcγR家族:抗体药物研发的基石与核心靶点
945
2026-04-20
【应用方向】CD47-SIRPα轴研究工具与药物开发应用
821
2026-04-20
【技术讲解】ADC药物研究相关靶点汇总
19371
2025-07-30
【应用方向】抗体药筛选的关键—靶点蛋白
11559
2025-07-09





